Product catalog antigen listed by alphabetic starting with C
| Items 401 to 500 of 2.562 total | 26 Page(s): |
Protein
| Catalog No. | Species | Presentation | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| GTX25859 | CaMK IV / CaMKGR (Control Peptide) antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| H00000815-P01-10 | CAMK2A / CaMK II alpha antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000815-P01-25 | CAMK2A / CaMK II alpha antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000815-Q01-10 | CAMK2A / CaMK II alpha antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000815-Q01-25 | CAMK2A / CaMK II alpha antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| NB300-313 | CAMK2A / CaMK II alpha antigen | ||||||
| Rat | Purified | - | Brain | 0.5 µg / --- | |||
| Novus Biologicals Inc. | |||||||
| NB300-314 | CAMK2A / CaMK II alpha antigen | ||||||
| Rat | Purified | - | Brain | 1 µg / --- | |||
| Novus Biologicals Inc. | |||||||
| H00000816-P01-10 | CAMK2B / CaMK II beta antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000816-P01-25 | CAMK2B / CaMK II beta antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000816-Q01-10 | CAMK2B / CaMK II beta antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000816-Q01-25 | CAMK2B / CaMK II beta antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000817-Q01-10 | CAMK2D / CaMK II delta antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000817-Q01-25 | CAMK2D / CaMK II delta antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000818-P01-10 | CAMK2G / CaMK II gamma antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000818-P01-25 | CAMK2G / CaMK II gamma antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00084254-P01-10 | CaMKK1 / CaMKK alpha antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00084254-P01-25 | CaMKK1 / CaMKK alpha antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010645-Q01-10 | CAMKK2 / CaMKK beta antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010645-Q01-25 | CAMKK2 / CaMKK beta antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00079012-P01-10 | CAMKV antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00079012-P01-25 | CAMKV antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000819-Q01-10 | CAMLG antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000819-Q01-25 | CAMLG antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| AR00022PU-N | Campylobacter jejuni Antigen | ||||||
| Purified | Cell culture | 1 mg / --- | |||||
| Acris Antibodies GmbH | |||||||
| AR00023PU-N | Cancer Antigen CA125 (Ovarian Cancer) Antigen Grade | ||||||
| Human | Purified | Cell culture | 50 kU / --- | ||||
| Acris Antibodies GmbH | |||||||
| AR00026PU-N | Cancer Antigen CA19-9 (Gastrointestinal Cancer) Antigen Grade | ||||||
| Human | Purified | Blood | 50 kU / --- | ||||
| Acris Antibodies GmbH | |||||||
| AR00027PU-N | Cancer Antigen CA19-9 (Gastrointestinal Cancer) Antigen Grade | ||||||
| Purified | 250 kU / --- | ||||||
| Acris Antibodies GmbH | |||||||
| AR00028PU-N | Cancer Antigen CA19-9 (Gastrointestinal Cancer) Antigen Grade | ||||||
| Human | Purified | Cell culture | 50 kU / --- | ||||
| Acris Antibodies GmbH | |||||||
| AR00011PU-N | Cancer Antigen CA72-4 Antigen Grade | ||||||
| Human | Purified | Blood | 20 kU / --- | ||||
| Acris Antibodies GmbH | |||||||
| H00055832-Q01-10 | CAND1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00055832-Q01-25 | CAND1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| AR00054PU-N | Candida albicans (Wild type) antigen | ||||||
| Purified | Cell culture | 1 mg / --- | |||||
| Acris Antibodies GmbH | |||||||
| H00001268-Q01-10 | Cannabinoid Receptor 1 / CNR1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00001268-Q01-25 | Cannabinoid Receptor 1 / CNR1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00124583-Q01-10 | CANT1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00124583-Q01-25 | CANT1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010487-P01-10 | CAP1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010487-P01-25 | CAP1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010486-P01-10 | CAP2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010486-P01-25 | CAP2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000822-P01-10 | CAPG antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000822-P01-25 | CAPG antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000822-Q01-10 | CAPG antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000822-Q01-25 | CAPG antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000823-Q01-10 | CAPN1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000823-Q01-25 | CAPN1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011131-Q01-10 | CAPN11 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00011131-Q01-25 | CAPN11 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000825-P01-10 | CAPN3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000825-P01-25 | CAPN3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000726-Q01-10 | CAPN5 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000726-Q01-25 | CAPN5 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010753-Q01-10 | CAPN9 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010753-Q01-25 | CAPN9 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000826-Q01-10 | CAPNS1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000826-Q01-25 | CAPNS1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00084290-P01-10 | CAPNS2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00084290-P01-25 | CAPNS2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000828-Q01-10 | CAPS antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000828-Q01-25 | CAPS antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000829-P01-10 | CapZ alpha-1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000829-P01-25 | CapZ alpha-1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000829-Q01-10 | CapZ alpha-1 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000829-Q01-25 | CapZ alpha-1 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 10-288-21950F | CapZ alpha-1 antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-21950F-50 | CapZ alpha-1 antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00000830-P01-10 | CAPZA2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000830-P01-25 | CAPZA2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000830-Q01-10 | CAPZA2 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000830-Q01-25 | CAPZA2 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00093661-Q01-10 | CAPZA3 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00093661-Q01-25 | CAPZA3 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000832-Q01-10 | CAPZB antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00000832-Q01-25 | CAPZB antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051181-P01-10 | Carbonyl reductase II antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051181-P01-25 | Carbonyl reductase II antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051181-Q01-10 | Carbonyl reductase II antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00051181-Q01-25 | Carbonyl reductase II antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00029775-Q01-10 | CARD10 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00029775-Q01-25 | CARD10 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00084433-Q01-10 | CARD11 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00084433-Q01-25 | CARD11 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00058484-Q01-10 | CARD12 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00058484-Q01-25 | CARD12 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00079092-Q01-10 | CARD14 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00079092-Q01-25 | CARD14 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00079092-Q02-10 | CARD14 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00079092-Q02-25 | CARD14 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| 10-288-21980F | CARD14 antigen | ||||||
| Human | Purified | 95% | E. coli | 0.1 mg / --- | |||
| GenWay Biotech Inc. | |||||||
| 10-288-21980F-50 | CARD14 antigen | ||||||
| Human | Purified | 95% | E. coli | 50 µg / --- | |||
| GenWay Biotech Inc. | |||||||
| H00010392-Q01-10 | CARD4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010392-Q01-25 | CARD4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010392-Q02-10 | CARD4 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00010392-Q02-25 | CARD4 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00084674-Q01-10 | CARD6 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00084674-Q01-25 | CARD6 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00022900-Q01-10 | CARD8 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00022900-Q01-25 | CARD8 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00064170-Q01-10 | CARD9 antigen | ||||||
| Human | in vitro transl. | 10 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| H00064170-Q01-25 | CARD9 antigen | ||||||
| Human | in vitro transl. | 25 µg / --- | |||||
| Abnova Taiwan Corp. | |||||||
| GTX29650 | CARD9 control peptide antigen | ||||||
| 50 µg / --- | |||||||
| GeneTex Inc. | |||||||
| Items 401 to 500 of 2.562 total | 26 Page(s): |


